Pacific Clinical Research Network

23/09/2025

Are you suffering from Ulcerative Colitis (UC)?

Pacific Clinical Research New Zealand is looking for adults aged 18-75 with Ulcerative Colitis (UC) to participate in a clinical research study investigating the effectiveness of a potential a new medication that could change the way UC is treated.

✅ No cost to participate
✅ Receive expert care throughout the study
✅ Compensation for time and travel

Interested? Call 0800 727 669

https://pcrn.co.nz/inflam/

10/09/2025

We’re proud to be collaborating with the University of Auckland's Centre for Brain Research and Dr Richard Roxburgh on a clinical trial testing a potential genetic therapy for facioscapulohumeral muscular dystrophy (FSHD).

This rare condition currently has no treatment that changes its course. The investigational therapy aims to use epigenetic editing delivered through a modified virus to suppress the faulty DUX4 gene.

This research represents an important step forward in understanding and managing FSHD for patients around the world.

👉 Read the full article here: https://www.auckland.ac.nz/en/news/2025/08/27/world-first-gene-therapy-trial-for-muscular-dystrophy.html

A groundbreaking genetic treatment for a rare form of muscular dystrophy is being trialled at the University of Auckland’s Centre for Brain Research.

08/09/2025

Exciting news from Tokyo 💙

Some of our PCRN team travelled to Japan for the Investigator Meeting of a new chronic migraine research study!

We’re proud to be working alongside Dr Ros Hill, who will lead the study in Auckland as our Principal Investigator.

Chronic migraine affects thousands of people in New Zealand and can be life-changing. This new study is a step toward finding better treatment options for those living with migraine.

👉 Stay tuned as we share more about how you or someone you know may be able to take part.

02/09/2025

See if you or your child is eligible at: https://pcrn.co.nz/current-trials/

We're a Clinical research company driven by our purpose of bringing more clinical trials to New Zealand & helping more patients access clinical research.